Marathon Trading Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,000
Closed -$531K 211
2020
Q1
$531K Hold
3,000
0.1% 95
2019
Q4
$574K Sell
3,000
-5,500
-65% -$992K 0.04% 137
2019
Q3
$1.43M Buy
8,500
+6,500
+325% +$1.06M 0.25% 80
2019
Q2
$335K Buy
+2,000
New +$277K 0.03% 173
2017
Q4
Sell
-1,900
Closed -$389K 200
2017
Q3
$389K Buy
+1,900
New +$442K 0.04% 106
2016
Q2
Sell
-1,550
Closed -$415K 153
2016
Q1
$415K Buy
+1,550
New +$444K 0.08% 98
2015
Q3
Sell
-3,000
Closed -$910K 461
2015
Q2
$910K Buy
+3,000
New +$895K 0.04% 251

Other funds holding AGN

Marathon Trading Investment Management's AGN Position: Q2 2020 in Review

Marathon Trading Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,000 shares — an estimated $531K sold.

Marathon Trading Investment Management first reported a position in AGN in Q2 2015 and held it in 7 quarters. The position peaked at $1.43M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Marathon Trading Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Marathon Trading Investment Management sold 3,000 Allergan plc shares in Q2 2020, an estimated $531K.
  • Marathon Trading Investment Management first reported a position in Allergan plc in Q2 2015 and held it in 7 quarters.
  • Marathon Trading Investment Management's Allergan plc position peaked at $1.43M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Marathon Trading Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.